What changes will be made to intellectual property laws?
TPP harmonises intellectual property rules across the 12 countries which has
required compromise from all parties.
New Zealand currently has a 50-year copyright period. 2 However, half the TPP
countries, and almost all OECD countries, have a 70-year period for copyright
works. TPP requires New Zealand to move to 70 years as well, but allows for a
transition to do this over time.
...
Apart from these two changes, TPP does not affect what is or isn’t subject to
copyright. New Zealand will maintain its current copyright exceptions and will not
be prohibited from adopting new ones in the future. In addition, New Zealand will
not be prevented from undertaking a review of its copyright laws.
New Zealand has, however, agreed to extend its existing laws on technological
protection measures (TPMs), which control access to digital content like music,
TV programmes, films and software. Circumventing TPMs will be prohibited but
exceptions will apply to ensure that people can still circumvent them where there
is no copyright issue (for example, playing region-coded DVDs purchased from
overseas) or where there is an existing copyright exception (for example,
converting a book to braille).
...
In addition, TPP will not affect current New Zealand law on
software patents or require methods of medical treatment to be patentable.
...
What does TPP mean for medicines?
Consumers will not pay more for subsidised medicines as a result of TPP. Most
prescription medicines are fully subsidised and, with few exceptions, New
Zealanders pay no more than $5. TPP does not change this in any way.
Few additional costs are expected for the Government as well.
Under TPP there is no change to New Zealand’s standard 20-year patent period,
but countries will have to extend the term of a particular pharmaceutical patent if
there are unreasonable delays in examining the patent or getting regulatory
approval. New Zealand’s processes are efficient, however, so very few patent
term extensions are expected, based on current practice, and only in exceptional
circumstances.
...
A number of earlier, far-reaching proposals relating to medicines and to
PHARMAC were knocked back during the TPP negotiations and are not part of
the final agreement.